FGFR2 rs11199874: What Your Genotype Means
The rs11199874 variant is a single nucleotide polymorphism located within the FGFR2 gene region. It has been identified in scientific research as a genetic marker associated with variations in prostate-specific antigen (PSA) levels and prostate cancer risk.
What each genotype means
Baseline prostate cancer risk
This genotype represents the common baseline state for this genetic marker in the FGFR2 gene. Research indicates that individuals with this genotype do not carry the specific allele associated with increased prostate cancer risk or altered PSA levels at this locus. Please note that genetic risk is only one factor in health, and you should discuss your overall prostate health and screening needs with your physician.
This is the most common genotype observed in populations of European ancestry.
Slightly altered risk profile
Carrying one copy of the variant allele is associated with minor shifts in prostate-specific antigen (PSA) levels and a statistically modest change in prostate cancer risk. Because this association is based on population-level data, it does not predict an individual outcome. You should continue to follow standard medical guidelines for prostate health and discuss any concerns with your healthcare provider.
This heterozygous genotype is found in a significant portion of individuals of European ancestry.
Increased prostate cancer risk
This genotype is associated with a higher statistical likelihood of altered PSA levels and an increased risk of developing prostate cancer compared to the baseline. This association is derived from large-scale genome-wide studies, but it is not a diagnostic indicator of disease. It is important to maintain regular health screenings and discuss your family history and personal risk factors with your clinician.
This genotype is less common than the AA or AG genotypes in most European-ancestry populations.
Understanding the rs11199874 Variant
The rs11199874 variant is a specific change in the DNA sequence, known as a single nucleotide polymorphism (SNP), located on chromosome 10. It sits within a region of the genome that encompasses the FGFR2 gene. In genetics, SNPs are the most common type of variation among people, representing a difference in a single building block of DNA. While many SNPs have no effect on health, researchers study them to understand how specific regions of our DNA might influence susceptibility to complex conditions. This particular variant has been highlighted in genome-wide association studies (GWAS) as a point of interest for researchers investigating the genetic architecture of prostate health.
The Role of the FGFR2 Gene
The FGFR2 gene provides instructions for making a protein called fibroblast growth factor receptor 2. This protein is part of a family of receptors that play critical roles in cell signaling, growth, and development. By receiving signals from outside the cell, FGFR2 helps regulate processes such as cell division, migration, and survival. Because these processes are fundamental to how tissues grow and maintain themselves, changes in the regulation or function of FGFR2 can have broad biological implications. In the context of cancer research, scientists are particularly interested in how variations in this gene might influence the behavior of prostate cells, potentially contributing to the development or progression of prostate-related conditions.
Research and Evidence Strength
Scientific evidence linking rs11199874 to prostate cancer risk is considered moderate. Research, including data from large-scale genome-wide association studies, has identified this SNP as being statistically associated with both prostate cancer risk and levels of prostate-specific antigen (PSA). It is important to note that these findings represent statistical correlations observed across large groups of people rather than a direct cause-and-effect relationship for any single individual. The association is part of a broader body of research exploring how multiple genetic markers, often working in combination with environmental and lifestyle factors, contribute to complex health traits. Because prostate cancer is a multifactorial disease, this variant is just one of many pieces in a very large and complex genetic puzzle.
What This Information Means for You
It is essential to understand that having a specific genotype at the rs11199874 locus does not mean you will or will not develop prostate cancer. Genetic markers like this are used by scientists to better understand disease mechanisms at a population level, not to provide individual medical diagnoses or risk assessments. If you are concerned about your prostate health or have questions about PSA screening, the most appropriate step is to consult with a healthcare professional. They can provide guidance based on your personal and family medical history, which are far more predictive of your health outcomes than any single genetic variant. Never use information about genetic variants to make decisions about your medical care or to alter any prescribed treatments without professional clinical advice.
How common is this variant?
The rs11199874 variant is commonly observed across populations of European ancestry. Frequency data can vary significantly between different ethnic and ancestral groups.
Frequently asked questions
Does having the rs11199874 variant mean I have prostate cancer?
No. This variant is a genetic marker associated with a statistical difference in risk at a population level. It is not a diagnostic test for prostate cancer.
Should I get tested for this SNP?
Genetic testing for common variants like rs11199874 is generally not recommended for clinical decision-making. Prostate health is best managed through regular screenings and discussions with your doctor.
How does FGFR2 affect prostate health?
FGFR2 is involved in cell signaling and growth. Researchers study it to understand how its activity might influence the development of prostate cells, but the exact biological mechanisms are still being investigated.
Where can I find more information on prostate cancer risk?
You can consult reputable medical resources such as the American Cancer Society or the National Cancer Institute. Always discuss your specific health concerns with a qualified physician.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11199874?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FGFR2
Intronic variant in FGFR2 associated with increased risk of estrogen receptor-positive breast cancer.
This SNP is associated with an increased susceptibility to breast cancer.
This variant is associated with an increased risk of breast cancer in various populations.
One of the strongest common genetic risk factors for breast cancer.
This intronic variant in the FGFR2 gene has been associated with susceptibility to BRCA2-related breast cancer.
This variant is strongly correlated with prostate cancer aggressiveness and serum PSA levels.